M. Ozkan Et Al. , "Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer patients treated with erlotinib," JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018
Ozkan, M. Et Al. 2018. Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer patients treated with erlotinib. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15 .
Ozkan, M., Dogan, E., Canoz, Ö., Sakalar, T., Derin, S., & Bozkurt, O., (2018). Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer patients treated with erlotinib. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.
Ozkan, Metin Et Al. "Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer patients treated with erlotinib," JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018
Ozkan, Metin Et Al. "Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer patients treated with erlotinib." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018
Ozkan, M. Et Al. (2018) . "Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer patients treated with erlotinib." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.
@article{article, author={Metin Ozkan Et Al. }, title={Differences between epidermal growth factor receptor mutation status and clinic and radiologic features in metastatic lung adenocancer patients treated with erlotinib}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2018}